Detalles de la búsqueda
1.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med;
381(21): 2009-2019, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31693803
2.
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Lancet;
395(10234): 1434-1443, 2020 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197107
3.
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Rev Panam Salud Publica;
45: e67, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131423
4.
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
Lancet;
385(9971): 857-66, 2015 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25684586
5.
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine;
41(7): 1398-1407, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36681529
6.
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
PLoS Negl Trop Dis;
17(3): e0011124, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36888687
7.
Physiological effects of roflumilast at rest and during exercise in COPD.
Eur Respir J;
39(5): 1104-12, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21965226
8.
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Lancet;
374(9691): 695-703, 2009 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-19716961
9.
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial.
Vaccine;
38(6): 1513-1519, 2020 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31843269
10.
Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study.
Lancet Infect Dis;
18(2): 162-170, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29122463
11.
Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD.
Respir Med;
108(2): 366-75, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24120253
12.
Roflumilast for the treatment of COPD in an Asian population: a randomized, double-blind, parallel-group study.
Chest;
145(1): 44-52, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24135893
13.
Efficacy of roflumilast in the COPD frequent exacerbator phenotype.
Chest;
143(5): 1302-1311, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23117188
Resultados
1 -
14
de 14
1
Próxima >
>>